Trials / Sponsors / BioAtla, Inc.
BioAtla, Inc.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma. Advanced Adenocarcinoma | Phase 1 | 2023-07-14 |
| Completed | A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the H Head and Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Recurrent Squamous Cell Carcinoma of the Head and Neck | Phase 2 | 2022-12-13 |
| Active Not Recruiting | A Phase 1/2 Study of BA3071 in Patients With Solid Tumors NSCLC, Melanoma | Phase 1 / Phase 2 | 2022-08-03 |
| Completed | CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC Non-Small-Cell Lung Cancer | Phase 2 | 2021-03-17 |
| Completed | CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Melanoma | Phase 1 / Phase 2 | 2018-06-27 |
| Completed | CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma | Phase 1 / Phase 2 | 2018-02-15 |